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Severity of Reaction

Symptoms
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Treatment

Mild Reactions

For example flushing that is not
bothersome to the patient

Antihistamines are usually not necessary,
restart the infusion at one-half the previous rate.

Moderate Reactions

For example the patient is uncomfortable
due to flushing or pruritus.Hemodynamically stable, not experiencing chest pain
or muscle spasm

Treatment with an antihistamine such as clemastine or diphenhydramine (Grade 2C) is suggested.

For example muscle spasms, chest pain,
hypotension etc

In addition to stopping the infusion, administration
of H1 antihistamine intravenously (clemastine etc)
and H2 antihistamine intravenously (ranitidine) is
recommended. (Grade 2C) IV fluids for hypotension may be needed. Infuse any subsequent dose of
Vancomycin over four hours.

Severe Reactions

Leflunomide

Increased risk of severe liver injury in patients using this drug

Tramadol

Risk of suicide for patients who are addiction-prone, taking tranquilisers or antidepressant drugs

PPIs’

Increased risk of fractures of hip, wrist and spine bones

GnRH Agonists

Increased risk of diabetes and cardiovascular events in patients receiving GnRH agonists

Propylthiouracil

Reports of severe liver injury and acute liver failure. Patients should be closely monitored for signs and
symptoms of liver injury during the six months of therapy initiation

Simvastatin

Increased risk of muscle injury (myopathy) with high doses
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High Risk Diagnosis

Recording High Risk Diagnosis in NPHA
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